BT8009: A bicyclic peptide toxin conjugate targeting Nectin-4 (PVRL4) displays efficacy in preclinical tumor models

被引：7

作者：

Rigby, Mike ^{[1
]}

Beswick, Paul ^{[1
]}

Mudd, Gemma ^{[1
]}

Van Rietschoten, Katerine ^{[1
]}

Chen, Liuhong ^{[1
]}

Watcham, Sophie M. ^{[1
]}

Allen, Heather ^{[1
]}

Brown, Amy ^{[1
]}

Harrison, Helen ^{[1
]}

Bennett, Gavin ^{[1
]}

Jeffrey, Phil ^{[1
]}

Park, Peter U. ^{[2
]}

Koehler, Maria ^{[2
]}

Keen, Nicholas ^{[2
]}

机构：

[1] Bicycle Therapeut Ltd, Cambridge, England

[2] Bicycle Therapeut Inc, Lexington, MA USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-4479

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4479

引用

页数：2

共 25 条

[21] BT5528, a Bicycle Toxin Conjugate targeting EphA2 has potent anti-tumor activity without bleeding or coagulation abnormalities in preclinical models
Bennett, Gavin
Huxley, Philip
Brown, Amy
Mudd, Gemma
Park, Peter U.
Keen, Nicholas
CANCER RESEARCH, 2018, 78 (13)
[22] Enfortumab vedotin, a Nectin-4 directed ADC, demonstrates compelling tolerability and anti-tumor activity with intravesical instillation in preclinical models of non-muscle invasive bladder cancer
Carosino, Christopher
Olson, Devra
Snead, Katie
Lee, Anthony
Farr, Lauren
Garg, Amit
O'Day, Christine
Trueblood, Esther
Wright, Jennifer
Bieda, Mark
Caldwell, Charles
Hensley, Kelly
Allred, Sean
Liu, Bernard
Shimazaki, Masashi
Sandall, Sharsti
CANCER RESEARCH, 2022, 82 (12)
[23] Efficacy and safety of 9 MW2821, an antibody-drug conjugate targeting Nectin-4 monotherapy, in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, phase I/II study
Yang, Huijuan
Zhang, Jian
Liu, Rujiao
Gao, Shuiping
Lou, Hanmei
Li, Guiling
Bu, Hualei
Li, Rong
Wang, Shanbing
Shen, Shujing
Zhang, Mingjun
Wang, Peipei
Feng, Zhe
Chu, Nan
GYNECOLOGIC ONCOLOGY, 2024, 190 : S22 - S23
[24] A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models
Wang, Ruixue
Lai, Qinhuai
Tang, Liangze
Tao, Yiran
Yao, Yuqin
Liu, Yu
Lu, Ying
Shen, Chaoyong
Lu, Ran
Fan, Chuanwen
Zhang, Ruirui
Wang, Yuxi
Yu, Lin
Yang, Tinghan
Wu, Yangping
Peng, Yujia
Wei, Xian
Fu, Yuyin
Lai, Weirong
Gou, Lantu
Yang, Jinliang
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (04): : 610 - +
[25] ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical Models
Smith, Roger A.
Zammit, David J.
Damle, Nitin K.
Usansky, Helen
Reddy, Sanjeeva P.
Lin, Jun-Hsiang
Mistry, Mahesh
Rao, Niranjan S.
Denis, Louis J.
Gupta, Sandeep
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (08) : 1327 - 1337

← 1 2 3 →